Trial in progress: A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors Meeting Abstract

  

Authors:	Schoenfeld, A. J.; Warner, A. B.; Thomas, S. S.; Hamid, O.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; Prabhakar, P.; McLaughlin, L.; Chesney, J. A.
Abstract Title:	Trial in progress: A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors
Meeting Title:	27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Journal Title:	Molecular Therapy
Volume:	32
Issue:	4 Suppl. 1
Meeting Dates:	2024 May 7-11
Meeting Location:	Baltimore, MD
ISSN:	1525-0016
Publisher:	Nature Publishing Group
Date Published:	2024-04-22
Start Page:	881
Language:	English
ACCESSION:	WOS:001332783403314
PROVIDER:	wos
DOI:	10.1016/j.ymthe.2024.04.020
Notes:	Meeting Abstract: 1895 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/221095